Rubicon Organics Reports Q1 2024 Financial Results Achieved net revenue of $8.9 million for the three months ended March 31, 2024Adjusted EBITDA1 loss of $0.4 million for the three months ended March 31, 2024Negative operating cash flow of $0.9 million for the three months ended March 31, 2024Number one premium licenced producer across all categories22.0%3 national market share of flower and pre-rolls for the three months ended March 31, 20247.1%4 national market share of premium flower and pre-rolls for the three months ended March 31, 2024WildflowerTM is the number one topical brand in Ca...
KEY HIGHLIGHTS Results First Resources (FR SP/BUY /S$1.42/Target: S$1.65) 1Q24: Results within expectations. Frencken Group (FRKN SP/BUY/S$1.40/Target: S$1.74) 1Q24: Results within expectations; outlook remains optimistic. Maintain BUY. StarHub (STH SP/BUY/S$1.25/Target: S$1.41) 1Q24: Results in line; DARE+ benefits likely to come through by end-24. Update Riverstone Holdings (RSTON SP/BUY/S$0.93/S$1.12) Beneficiary of US tariff hike and gl...
Remitly Announces May 2024 Investor Conference Participation SEATTLE, May 15, 2024 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ: RELY) (“Remitly”), a trusted provider of digital financial services that transcend borders, today announced that its management team will participate in the following investor conferences: Barclays 14th Annual Emerging Payments and FinTech ForumDate: Thursday, May 16, 2024 J.P. Morgan 52nd Annual Global Technology, Media and Communications ConferenceDate: Monday, May 20, 2024Time: 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time The J.P. Morgan presentatio...
Moody's Ratings (Moody's) announced that the purchase of AUD16.6 million of mortgages into PB 2022-1R Trust on 16 May 2024 (the "Substitution") would not, in and of itself and as of this point in time, result in a reduction, placement on review for possible downgrade or withdrawal of Moody's current...
NOVONIX Announces Completion of Due Diligence for Combination of Natural Graphite Interests into Axon Graphite BRISBANE, Australia, May 16, 2024 (GLOBE NEWSWIRE) -- NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX”), a leading battery materials and technology company, today announced that due diligence has been satisfactorily completed for both NOVONIX and Lithium Energy Limited (ASX: LEL)(“LEL”) to contribute their natural graphite exploration interests into a new company, Axon Graphite Limited (“Axon”). As previously announced, NOVONIX has agreed to divest MD South Tenements Pty L...
Assure & Danam Postpone Corporate Update Call & Webcast Scheduled for May 16 DENVER, May 15, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced today that the joint corporate update call with Danam scheduled for Thursday, May 16, 2024 at 4 p.m. Eastern Time has been postponed. The Company plans to reschedule the conference call at a later date. About Assure Holdings Assure Holdings Corp. is a best-in-class provider of outsourced intraoperative neu...
Webcast Alert: Cavco Industries, Inc. Announces Fiscal 2024 Fourth Quarter and Year End Earnings Release and Conference Call Webcast PHOENIX, May 15, 2024 (GLOBE NEWSWIRE) -- Cavco Industries, Inc. (Nasdaq: CVCO) will release earnings for the fourth quarter and fiscal year ended March 30, 2024 on Thursday, May 23, 2024 after the close of market. Senior management will discuss the results in a live webcast the following day, Friday, May 24, 2024 at 1:00 p.m. Eastern Time. Date: May 24, 2024 Time: 1:00 p.m. ET Listen via Internet: Listen via Telephone: ...
Moody's Ratings (Moody's) assigned A2 to Oncor Electric Delivery Company LLC's (Oncor) senior secured notes denominated in Euros ("Euronotes"). This is Oncor's inaugural Euronotes issuance. The rating outlook is stable. RATINGS RATIONALE The A2 rating assigned to the Euronotes is in line with On...
MEXICO CITY--(BUSINESS WIRE)-- BBB Foods Inc. (NYSE: TBBB) (“Tiendas 3B” or “the Company”) will report its first quarter 2024 earnings on May 22, 2024, after market close. You are invited to join our quarterly conference call, which will be webcast on May 23, 2024, at 11:00 a.m. ET. Anthony Hatoum, Chairman and CEO, and Eduardo Pizzuto, CFO, will host the call and take questions on the results. Event: Tiendas 3B First Quarter 2024 Results When: May 23, 2024, 11:00 a.m. ET Webinar /Dial In #: To join the webinar: To join via telephone: Dial one of the domestic or international nu...
Moody's Ratings (Moody's) has assigned a rating to one class of refinancing notes (the "Refinancing Notes") issued by Sound Point CLO XXI, Ltd. (the "Issuer"). Moody's rating action is as follows: U.S.$315,000,000 Class A-1A-R Senior Secured Floating Rate Notes Due 2031 (the "Class A-1AR Notes"...
Moody's Ratings (Moody's) has assigned ratings to two classes of notes issued by Hildene TruPS Resecuritization P26BC, LLC (the "Issuer"). Moody's rating action is as follows: U.S.$66,000,000 Class A Notes due 2037, Assigned Baa2 (sf) U.S.$40,000,000 Class B Notes due 2037, Assigned B1 (sf) T...
NÜRTINGEN, Allemagne--(BUSINESS WIRE)-- ADS-TEC Energy annonce aujourd'hui que ChargePost a remporté un prix allemand de l'innovation dans la catégorie Excellence in Business to business : E-Mobility Technologies, en reconnaissance de son design, de sa marque et de son innovation. ChargePost est une station de charge rapide à batterie, développée et produite en Allemagne, qui permet de recharger les véhicules électriques hors réseau en quelques minutes. Le jury a déclaré : « Avec la station de recharge rapide ChargePost d'ADS-TEC Energy, les longs temps d'attente lors des recharges de voitures...
Inhibikase Therapeutics Reports First Quarter Financial Results and Highlights Recent Period Activity Company to host conference call on Thursday, May 16, 2024 at 8:00 a.m. ET BOSTON and ATLANTA, May 15, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases, today reported financial results for the first quarter ended March 31, 2...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.